Uni-asia Cancer hospital
China, Chengdu
Liao Zhengyin
35 years of experience • 100000+ treatments performed
Surgeon's portfolio
| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | — / 5 | Chengdu, China | 35+ years100,000+ treatments | Transarterial chemoembolization (TACE), NanoKnife ablation, iodine-125 brachytherapy, stereotactic body radiotherapy (SBRT), chemotherapy with targeted and immunotherapy, molecular testing for driver genes | Advanced, recurrent, or inoperable adenocarcinoma patients | Minimally invasive NanoKnife ablation targets tumors without open surgery. Surgeons have performed 100,000+ interventional procedures each, including 4,000+ complex cases. Multidisciplinary team manages advanced, recurrent, and metastatic cases. | — |